I have practiced martial arts now for more than 11 years and would like to understand why I don't feel some pain associated with the techniques applied to so…
William Schmidt is an independent consultant to drug companies and emerging biotech companies around the world, helping to design clinical trials of new analgesic compounds. He also heads clinical…
EDITOR'S NOTE: For this Inaugural Forum, Jeffrey Mogil of McGill University raises the question why have the fruits of basic research in the pain field not translated into new…
A deepening chasm separates the knowledge obtained from a physician touching a patient with persistent pain and the expression of this knowledge in an animal model.
Clifford Woolf, MB, BCh, PhD focuses on the basic mechanisms of pain, and translating discoveries into new therapeutics and diagnostics. He is best known for the discovery of central…
Neurologists have by tradition separated disorders of the central nervous system from those affecting the peripheral nervous system. Arguments for this distinction have noted the role of the blood-brain-barrier…
The hypothesis offered by Reichling and Levine is interesting and provocative. However, the peripheral abnormalities they cite seem likely to be of marginal clinical significance for the chronic pain… more
Does the brain process and interpret innocuous and noxious stimuli by “reading” a pattern of activity across multimodal lines of activity, or are there specific, labeled lines that carry…
This discussion by Alan Basbaum and Clifford Woolf deserves more attention than it has received, at least as judged by the number of commentaries. Conceptual… more
Kathleen Foley, MD, has been caring for patients with cancer pain for over 40 years. Since 1974, she has been an attending neurologist at Memorial Sloan-Kettering Cancer Center in…
EDITOR'S NOTE: Shan Lou is a graduate student in the lab of Quifu Ma, Dana Farber Cancer Institute and Harvard Medical School, Boston, Massachusetts, where she studies the development of…
EDITOR’S NOTE: In this analysis, Vincenzo Di Marzo discusses recent developments in understanding endocannabinoid actions and metabolism, and efforts to target these lipid mediators as a novel approach to…
Diabetic neuropathic pain is mainly seen in Type II diabetes in the clinical situation. However, the model widely used is the streptozotocin (STZ)-induced diabetic neuropathy model in rats. Is there…
Last comment: Donald Dalley, 18 May 2012